HALL LAURIE J TRUSTEE - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q4 2022$2
-99.9%
40
-33.3%
0.00%0.0%
Q3 2022$2,000
-60.0%
60
-33.3%
0.00%
-50.0%
Q2 2022$5,000
-28.6%
900.0%0.00%
-33.3%
Q1 2022$7,000
-12.5%
900.0%0.00%0.0%
Q4 2021$8,0000.0%900.0%0.00%0.0%
Q3 2021$8,000
-38.5%
90
-35.7%
0.00%
-40.0%
Q2 2021$13,000
-18.8%
1400.0%0.01%
-16.7%
Q1 2021$16,000
-15.8%
1400.0%0.01%
-25.0%
Q4 2020$19,000
+58.3%
1400.0%0.01%
+60.0%
Q3 2020$12,000
+200.0%
140
+40.0%
0.01%
+150.0%
Q4 2019$4,0001000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders